Gene · 4688
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs in the Regulation of NADPH Oxidases in Vascular Diabetic and Ischemic Pathologies: A Case for Alternate Inhibitory Strategies? | Antioxidants (Basel) | 2022 | 36670932 | PubTator, text mining | PubMed |
| Role of Phosphoinositide 3-Kinase in Regulation of NOX-Derived Reactive Oxygen Species in Cancer. | Antioxidants (Basel) | 2022 | 36670929 | PubTator, text mining | PubMed |
| Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation. | Front Pharmacol | 2022 | 36642989 | PubTator, text mining | PubMed |
| Interstitial Lung Disease in Immunocompromised Children. | Diagnostics (Basel) | 2022 | 36611354 | PubTator, text mining | PubMed |
| Precision medicine: The use of tailored therapy in primary immunodeficiencies. | Front Immunol | 2022 | 36569887 | PubTator, text mining | PubMed |
| Anti-Inflammatory Neutrophil Functions in the Resolution of Inflammation and Tissue Repair. | Cells | 2022 | 36552840 | PubTator, text mining | PubMed |
| Oxidative Regulation of Vascular Cav1.2 Channels Triggers Vascular Dysfunction in Hypertension-Related Disorders. | Antioxidants (Basel) | 2022 | 36552639 | PubTator, text mining | PubMed |
| Inhibition of NADPH Oxidases Prevents the Development of Osteoarthritis. | Antioxidants (Basel) | 2022 | 36552552 | PubTator, text mining | PubMed |
| The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review. | Cancers (Basel) | 2022 | 36551737 | PubTator, text mining | PubMed |
| O-GlcNAc-Mediated Regulation of Galectin Expression and Secretion in Human Promyelocytic HL-60 Cells Undergoing Neutrophilic Differentiation. | Biomolecules | 2022 | 36551191 | PubTator, text mining | PubMed |
| Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma. | Front Genet | 2022 | 36531216 | PubTator, text mining | PubMed |
| Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD. | Front Immunol | 2022 | 36524121 | PubTator, text mining | PubMed |
| Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence. | Nat Commun | 2022 | 36522333 | PubTator, text mining | PubMed |
| Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking. | Front Endocrinol (Lausanne) | 2022 | 36506045 | PubTator, text mining | PubMed |
| Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection. | Front Immunol | 2022 | 36505429 | PubTator, text mining | PubMed |
| Protective Effect and Mechanism of Placenta Extract on Liver. | Nutrients | 2022 | 36501102 | PubTator, text mining | PubMed |
| Lupus Nephritis: Current Perspectives and Moving Forward. | J Inflamm Res | 2022 | 36483271 | PubTator, text mining | PubMed |
| Novel Role of Mammalian Cell Senescence-Sustenance of Muscle Larvae of Trichinella spp. | Oxid Med Cell Longev | 2022 | 36478989 | PubTator, text mining | PubMed |
| A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. | Nat Commun | 2022 | 36473860 | PubTator, text mining | PubMed |
| Neuroendocrinology of the lung revealed by single-cell RNA sequencing. | Elife | 2022 | 36469459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4688/papers?page=19